Mersana Therapeutics buy JPMorgan Chase & Co.
Start price
16.03.23
/
50%
€4.32
Target price
16.03.24
€9.45
Performance (%)
3.36%
End price
17.03.24
€4.47
Summary
This prediction ended on 17.03.24 with a price of €4.47. With a performance of 3.36%, the BUY prediction by JPMorgan_Chase___Co_ for Mersana Therapeutics closed with a slight gain. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Mersana Therapeutics | 3.553% | 3.553% | 65.057% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $10.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten